Splenectomy Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Splenectomy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

CirrhosisPortal Vein ThrombosisHypertension, Portal+1 more
Northern Jiangsu People's Hospital20 enrolled1 locationNCT07461532
Recruiting
Not Applicable

Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS

CirrhosisPortal Vein ThrombosisHypertension, Portal+1 more
Northern Jiangsu People's Hospital20 enrolled1 locationNCT07461545
Recruiting

Development of an Italian Questionnaire for Splenectomized Patients Using a Delphi Consensus Method

AspleniaSplenectomy; StatusSplenectomized Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS20 enrolled1 locationNCT07428005
Recruiting

Evaluation of the Effectiveness of an Educational Intervention in Splenectomized Patients

AspleniaSplenectomy; StatusSplenectomy+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS100 enrolled2 locationsNCT07354893
Recruiting
Phase 3

Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.

Splenectomy
Assistance Publique - Hôpitaux de Paris84 enrolled1 locationNCT04166656
Recruiting
Not Applicable

Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients

Cirrhoses, LiverSplenectomy; StatusPartial
Northern Jiangsu People's Hospital30 enrolled1 locationNCT07205471
Recruiting

Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations

Splenectomy
Assistance Publique - Hôpitaux de Paris100 enrolled5 locationsNCT06418256
Recruiting
Not Applicable

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Cirrhosis, LiverSplenectomy; Status
Northern Jiangsu People's Hospital20 enrolled1 locationNCT05338294
Recruiting
Not Applicable

The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients

Cirrhosis, LiverSplenectomy; Status
Northern Jiangsu People's Hospital20 enrolled1 locationNCT05325424
Recruiting
Not Applicable

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients

Cirrhosis, LiverPortal HypertensionSplenectomy; Status
Northern Jiangsu People's Hospital20 enrolled1 locationNCT05325437
Recruiting

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

ThrombocytopeniaSplenectomy
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT03998059
Recruiting
Phase 2

Meningococcal B Vaccine in Patients with Asplenia

Splenectomy; Status
Medical University of Vienna80 enrolled1 locationNCT06025487